Cargando…
Genetic heterogeneity in response to adenovirus gene therapy
BACKGROUND: After intravenous delivery of the adenoviral vector into rats or mice, 95–99% of the encoded protein is produced in the hepatocytes. We observed, as have others, that the early expression levels of the vector encoded protein vary, greatly, within a species, from one animal strain to anot...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC155537/ https://www.ncbi.nlm.nih.gov/pubmed/12697054 http://dx.doi.org/10.1186/1471-2199-4-4 |